*ST綠康(002868.SZ):擬將綠康生化南浦廠區及福建綠安生物廠區搬遷至浦潭生物產業園區
格隆匯7月31日丨*ST綠康(002868.SZ)公佈,公司於近日收到福建浦城工業園區管理委員會出具的《關於啓動南浦生態園區綠康生化股份有限公司及福建綠安生物農藥有限公司廠區搬遷和用地收儲工作的通知》。綠康生化現有兩個廠區分別位於南浦生態園區(簡稱“南浦廠區”)、浦潭生物產業園區。控股子公司福建綠安生物農藥有限公司(簡稱“福建綠安生物”)廠區位於南浦生態園區。隨着浦城縣經濟發展、城區擴容,居民住宅區距離南浦生態園區越來越近,爲進一步落實環保督察問題整改、有效改善城區空氣質量、建設美麗城市,同時爲加快推進產業集聚,根據浦城縣新一輪的產業規劃調整,將綠康生化南浦廠區及福建綠安生物廠區搬遷至浦潭生物產業園區。截至公告披露日,擬搬遷的綠康生化南浦廠區及福建綠安生物廠區仍在正常生產經營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.